{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T21:37:19Z","timestamp":1792186639301,"version":"4.4.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Metabolism"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.cmet.2026.01.001","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T15:33:43Z","timestamp":1769700823000},"page":"1113-1129.e12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Dual targeting of SLC25A51 and succinate dehydrogenase selectively depletes mitochondrial NAD+ to eradicate KRAS-driven AML"],"prefix":"10.1016","volume":"38","author":[{"given":"Ang","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Hao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongcan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongbo","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hangcheng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youli","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linzhang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingrong","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmei","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig T.","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong-Jin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haobin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmet.2026.01.001_bib1","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1182\/asheducation-2016.1.348","article-title":"Mutations in AML: prognostic and therapeutic implications","volume":"2016","author":"DiNardo","year":"2016","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/j.cmet.2026.01.001_bib2","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1056\/NEJMoa1112304","article-title":"Prognostic relevance of integrated genetic profiling in acute myeloid leukemia","volume":"366","author":"Patel","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cmet.2026.01.001_bib3","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic classification and prognosis in acute myeloid leukemia","volume":"374","author":"Papaemmanuil","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cmet.2026.01.001_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-024-01054-2","article-title":"RAS mutations in myeloid malignancies: revisiting old questions with novel insights and therapeutic perspectives","volume":"14","author":"Alawieh","year":"2024","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.cmet.2026.01.001_bib5","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1080\/10428194.2023.2190432","article-title":"Impact of KRAS and NRAS mutations on outcomes in acute myeloid leukemia","volume":"64","author":"Mustafa Ali","year":"2023","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.cmet.2026.01.001_bib6","doi-asserted-by":"crossref","first-page":"E171","DOI":"10.1002\/ajh.26146","article-title":"The prognosis and durable clearance of RAS mutations in patients with acute myeloid leukemia receiving induction chemotherapy","volume":"96","author":"Ball","year":"2021","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.cmet.2026.01.001_bib7","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1182\/blood.2024026925","article-title":"Refined ELN 2024 risk stratification improves survival prognostication following venetoclax-based therapy in AML","volume":"144","author":"Lachowiez","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.cmet.2026.01.001_bib8","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/s43018-020-00126-z","article-title":"Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells","volume":"1","author":"Stevens","year":"2020","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.cmet.2026.01.001_bib9","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/s41586-024-08137-x","article-title":"RAS-mutant leukaemia stem cells drive clinical resistance to venetoclax","volume":"636","author":"Sango","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.cmet.2026.01.001_bib10","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/s41591-022-01819-x","article-title":"A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia","volume":"28","author":"Zeng","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.cmet.2026.01.001_bib11","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/s41591-024-02903-0","article-title":"Targeting KRAS in cancer","volume":"30","author":"Singhal","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.cmet.2026.01.001_bib12","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41586-023-06123-3","article-title":"Pan-KRAS inhibitor disables oncogenic signalling and tumour growth","volume":"619","author":"Kim","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.cmet.2026.01.001_bib13","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1158\/2159-8290.CD-24-0840","article-title":"Discovery of BBO-8520, a first-in-class direct and covalent dual inhibitor of GTP-bound (ON) and GDP-bound (OFF) KRASG12C","volume":"15","author":"Maciag","year":"2025","journal-title":"Cancer Discov."},{"key":"10.1016\/j.cmet.2026.01.001_bib14","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.annonc.2025.01.020","article-title":"Genomic landscape of clinically acquired resistance alterations in patients treated with KRASG12C inhibitors","volume":"36","author":"Riedl","year":"2025","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.cmet.2026.01.001_bib15","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adp4986","article-title":"AGER-dependent macropinocytosis drives resistance to KRAS-G12D-targeted therapy in advanced pancreatic cancer","volume":"17","author":"Li","year":"2025","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cmet.2026.01.001_bib16","first-page":"1170","article-title":"Purine metabolites regulate leukemic cell sensitivity toward cytarabine","volume":"110","author":"Zhang","year":"2025","journal-title":"Haematologica"},{"key":"10.1016\/j.cmet.2026.01.001_bib17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.stem.2016.06.001","article-title":"Leukemic stem cells evade chemotherapy by metabolic adaptation to an adipose tissue niche","volume":"19","author":"Ye","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.cmet.2026.01.001_bib18","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.ccell.2018.08.016","article-title":"Subversion of systemic glucose metabolism as a mechanism to support the growth of leukemia cells","volume":"34","author":"Ye","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cmet.2026.01.001_bib19","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1158\/2159-8290.CD-20-0318","article-title":"The hepatic microenvironment uniquely protects leukemia cells through induction of growth and survival pathways mediated by LIPG","volume":"11","author":"Ye","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.cmet.2026.01.001_bib20","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.stem.2021.02.013","article-title":"Targeting energy metabolism in cancer stem cells: progress and challenges in leukemia and solid tumors","volume":"28","author":"Jones","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.cmet.2026.01.001_bib21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40170-021-00253-w","article-title":"Mitochondrial metabolism as a target for acute myeloid leukemia treatment","volume":"9","author":"Panina","year":"2021","journal-title":"Cancer Metab."},{"key":"10.1016\/j.cmet.2026.01.001_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116496","article-title":"A generalized strategy to kill leukemic cells by targeting the regulatory systems governing mitochondrial membrane potential","volume":"44","author":"Liu","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.cmet.2026.01.001_bib23","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/s41568-021-00375-9","article-title":"Metabolic networks in mutant KRAS-driven tumours: tissue specificities and the microenvironment","volume":"21","author":"Kerk","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cmet.2026.01.001_bib24","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s43018-021-00184-x","article-title":"The metabolic landscape of RAS-driven cancers from biology to therapy","volume":"2","author":"Mukhopadhyay","year":"2021","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.cmet.2026.01.001_bib25","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature12040","article-title":"Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway","volume":"496","author":"Son","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.cmet.2026.01.001_bib26","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1126\/science.aad5168","article-title":"Biosensor reveals multiple sources for mitochondrial NAD+","volume":"352","author":"Cambronne","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.cmet.2026.01.001_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe5310","article-title":"MCART1\/SLC25A51 is required for mitochondrial NAD transport","volume":"6","author":"Kory","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.cmet.2026.01.001_bib28","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41586-020-2741-7","article-title":"SLC25A51 is a mammalian mitochondrial NAD+ transporter","volume":"588","author":"Luongo","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cmet.2026.01.001_bib29","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.tem.2012.06.005","article-title":"The dynamic regulation of NAD metabolism in mitochondria","volume":"23","author":"Stein","year":"2012","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.cmet.2026.01.001_bib30","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.cmet.2024.01.013","article-title":"SLC25A51 decouples the mitochondrial NAD+\/NADH ratio to control proliferation of AML cells","volume":"36","author":"Lu","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.cmet.2026.01.001_bib31","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1038\/s41418-023-01185-2","article-title":"SLC25A51 promotes tumor growth through sustaining mitochondria acetylation homeostasis and proline biogenesis","volume":"30","author":"Li","year":"2023","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cmet.2026.01.001_bib32","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/sj.leu.2403236","article-title":"Malignant hematopoietic cell lines: in vitro models for the study of MLL gene alterations","volume":"18","author":"Drexler","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.cmet.2026.01.001_bib33","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41586-021-03662-5","article-title":"Phase separation drives aberrant chromatin looping and cancer development","volume":"595","author":"Ahn","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.cmet.2026.01.001_bib34","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1038\/leu.2010.207","article-title":"High frequencies of simultaneous FLT3-ITD, WT1 and KIT mutations in hematological malignancies with NUP98-fusion genes","volume":"24","author":"Taketani","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.cmet.2026.01.001_bib35","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.ccell.2022.07.002","article-title":"Integrative analysis of drug response and clinical outcome in acute myeloid leukemia","volume":"40","author":"Bottomly","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cmet.2026.01.001_bib36","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1021\/acs.jmedchem.1c01688","article-title":"Identification of MRTX1133, a noncovalent, potent, and selective KRASG12D inhibitor","volume":"65","author":"Wang","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cmet.2026.01.001_bib37","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1007\/s10637-021-01112-7","article-title":"First-in-human evaluation of the novel mitochondrial complex I inhibitor ASP4132 for treatment of cancer","volume":"39","author":"Janku","year":"2021","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.cmet.2026.01.001_bib38","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/nprot.2014.138","article-title":"The cellular thermal shift assay for evaluating drug target interactions in cells","volume":"9","author":"Jafari","year":"2014","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.cmet.2026.01.001_bib39","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ab.2006.07.027","article-title":"Thermofluor-based high-throughput stability optimization of proteins for structural studies","volume":"357","author":"Ericsson","year":"2006","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.cmet.2026.01.001_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.758","article-title":"Penfluridol inhibits melanoma growth and metastasis through enhancing von Hippel\u2012Lindau tumor suppressor-mediated cancerous inhibitor of protein phosphatase 2A (CIP2A) degradation","volume":"5","author":"Xu","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.cmet.2026.01.001_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202409498","article-title":"The antipsychotic drug aripiprazole suppresses colorectal cancer by targeting LAMP2a to induce RNH1\/miR-99a\/mTOR-mediated autophagy and apoptosis","volume":"11","author":"Hu","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.cmet.2026.01.001_bib42","doi-asserted-by":"crossref","DOI":"10.4028\/b-wjQRP6","article-title":"Targeting GRP75 with a chlorpromazine derivative inhibits endometrial cancer progression through GRP75-IP3R-Ca2+-AMPK axis","volume":"11","author":"Wang","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.cmet.2026.01.001_bib43","doi-asserted-by":"crossref","first-page":"5075","DOI":"10.1021\/acs.jmedchem.5b00468","article-title":"Identification of a potent inhibitor of CREB-mediated gene transcription with efficacious in vivo anticancer activity","volume":"58","author":"Xie","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cmet.2026.01.001_bib44","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.cell.2015.07.017","article-title":"Supporting aspartate biosynthesis is an essential function of respiration in proliferating cells","volume":"162","author":"Sullivan","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.cmet.2026.01.001_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-020-02867-2","article-title":"Venetoclax causes metabolic reprogramming independent of BCL-2 inhibition","volume":"11","author":"Roca-Portoles","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cmet.2026.01.001_bib46","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.devcel.2020.06.036","article-title":"Metabolites regulate cell signaling and growth via covalent modification of proteins","volume":"54","author":"Figlia","year":"2020","journal-title":"Dev. Cell"},{"key":"10.1016\/j.cmet.2026.01.001_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2019.06.028","article-title":"OGDH mediates the inhibition of SIRT5 on cell proliferation and migration of gastric cancer","volume":"382","author":"Lu","year":"2019","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.cmet.2026.01.001_bib48","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202256596","article-title":"Dynamics of SLC25A51 reveal preference for oxidized NAD+ and substrate led transport","volume":"24","author":"Goyal","year":"2023","journal-title":"EMBO Rep."},{"key":"10.1016\/j.cmet.2026.01.001_bib49","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/jnc.13096","article-title":"Alpha-ketoglutarate dehydrogenase complex-dependent succinylation of proteins in neurons and neuronal cell lines","volume":"134","author":"Gibson","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cmet.2026.01.001_bib50","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccr.2004.11.022","article-title":"Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase","volume":"7","author":"Selak","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cmet.2026.01.001_bib51","doi-asserted-by":"crossref","first-page":"24754","DOI":"10.1074\/jbc.273.38.24754","article-title":"The sequence, bacterial expression, and functional reconstitution of the rat mitochondrial dicarboxylate transporter cloned via distant homologs in yeast and Caenorhabditis elegans","volume":"273","author":"Fiermonte","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cmet.2026.01.001_bib52","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1038\/s42255-024-01174-w","article-title":"Subcellular NAD(+) pools are interconnected and buffered by mitochondrial NAD+","volume":"6","author":"Hoyland","year":"2024","journal-title":"Nat. Metab."},{"key":"10.1016\/j.cmet.2026.01.001_bib53","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12798","article-title":"Overexpression of Nmnat3 efficiently increases NAD and NGD levels and ameliorates age-associated insulin resistance","volume":"17","author":"Gulshan","year":"2018","journal-title":"Aging Cell"},{"key":"10.1016\/j.cmet.2026.01.001_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147037","article-title":"Nmnat3 is dispensable in mitochondrial NAD level maintenance in vivo","volume":"11","author":"Yamamoto","year":"2016","journal-title":"PLoS One."},{"key":"10.1016\/j.cmet.2026.01.001_bib55","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41586-020-2475-6","article-title":"Mitochondrial ubiquinol oxidation is necessary for tumour growth","volume":"585","author":"Mart\u00ednez-Reyes","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cmet.2026.01.001_bib56","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2004-5-10-r80","article-title":"Bioconductor: open software development for computational biology and bioinformatics","volume":"5","author":"Gentleman","year":"2004","journal-title":"Genome Biol."}],"updated-by":[{"DOI":"10.1016\/j.cmet.2026.07.026","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000}},{"DOI":"10.1016\/j.cmet.2026.07.026","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000}}],"container-title":["Cell Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155041312600001X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155041312600001X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T12:25:15Z","timestamp":1785932715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S155041312600001X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":56,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S155041312600001X"],"URL":"https:\/\/doi.org\/10.1016\/j.cmet.2026.01.001","relation":{},"ISSN":["1550-4131"],"issn-type":[{"value":"1550-4131","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual targeting of SLC25A51 and succinate dehydrogenase selectively depletes mitochondrial NAD+ to eradicate KRAS-driven AML","name":"articletitle","label":"Article Title"},{"value":"Cell Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmet.2026.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}